BioCentury | Jun 16, 2017
Financial News

Immuron raises $6.1M in follow-on and lists on NASDAQ

...to transfer its listing to NASDAQ from the Pink Sheets. Joseph Gunnar, H.C. Wainwright and WallachBeth Capital...
BioCentury | Apr 14, 2017
Financial News

Immuron amends follow-on

...10, Immuron Ltd. (ASX:IMC; Pink:IMROY) amended its follow-on to list its ADSs on NASDAQ adding WallachBeth Capital...
BioCentury | Oct 17, 2016
Financial News

AzurRx completes IPO

...Type: IPO Raised: $5.3 million Shares: 960,000 Price: $5.50 Shares after offering: 9.6 million Underwriters: WallachBeth Capital...
BioCentury | Oct 10, 2016
Financial News

AzurRx amends IPO

...Type: IPO To be raised: Up to $6.6 million Shares: 1.2 million Price: $5.50 Underwriters: WallachBeth Capital...
BioCentury | Sep 12, 2016
Financial News

AzurRx amends IPO

...Type: IPO To be raised: Up to $13.6 million Shares: 1.7 million Price: $6-$8 Underwriters: WallachBeth Capital...
BioCentury | Aug 1, 2016
Financial News

AzurRx amends IPO

...Type: IPO To be raised: Up to $15 million Shares: 2.1 million Price: $6-$8 Underwriters: WallachBeth Capital...
BioCentury | Jul 18, 2016
Financial News

AzurRx proposes IPO

...2016-07-13 Type: IPO To be raised: Up to $15 million Shares: TBD Price: TBD Underwriters: WallachBeth Capital...
BioCentury | May 16, 2016
Financial News

VistaGen completes follow-on

...million Shares: 2.4 million Price: $4.25 Shares after offering: 7.7 million Underwriters: Chardan Capital Markets; WallachBeth Capital...
BioCentury | May 9, 2016
Financial News

VistaGen amends follow-on

...raised: Up to $13.9 million Shares: 2.4 million Price prior: $8 Underwriters: Chardan Capital Markets; WallachBeth Capital...
BioCentury | Apr 25, 2016
Financial News

VistaGen amends follow-on

...be raised: Up to $13.8 million Shares: TBD Price Prior: $8 Underwriters: Chardan Capital Markets; WallachBeth Capital...
Items per page:
1 - 10 of 12
BioCentury | Jun 16, 2017
Financial News

Immuron raises $6.1M in follow-on and lists on NASDAQ

...to transfer its listing to NASDAQ from the Pink Sheets. Joseph Gunnar, H.C. Wainwright and WallachBeth Capital...
BioCentury | Apr 14, 2017
Financial News

Immuron amends follow-on

...10, Immuron Ltd. (ASX:IMC; Pink:IMROY) amended its follow-on to list its ADSs on NASDAQ adding WallachBeth Capital...
BioCentury | Oct 17, 2016
Financial News

AzurRx completes IPO

...Type: IPO Raised: $5.3 million Shares: 960,000 Price: $5.50 Shares after offering: 9.6 million Underwriters: WallachBeth Capital...
BioCentury | Oct 10, 2016
Financial News

AzurRx amends IPO

...Type: IPO To be raised: Up to $6.6 million Shares: 1.2 million Price: $5.50 Underwriters: WallachBeth Capital...
BioCentury | Sep 12, 2016
Financial News

AzurRx amends IPO

...Type: IPO To be raised: Up to $13.6 million Shares: 1.7 million Price: $6-$8 Underwriters: WallachBeth Capital...
BioCentury | Aug 1, 2016
Financial News

AzurRx amends IPO

...Type: IPO To be raised: Up to $15 million Shares: 2.1 million Price: $6-$8 Underwriters: WallachBeth Capital...
BioCentury | Jul 18, 2016
Financial News

AzurRx proposes IPO

...2016-07-13 Type: IPO To be raised: Up to $15 million Shares: TBD Price: TBD Underwriters: WallachBeth Capital...
BioCentury | May 16, 2016
Financial News

VistaGen completes follow-on

...million Shares: 2.4 million Price: $4.25 Shares after offering: 7.7 million Underwriters: Chardan Capital Markets; WallachBeth Capital...
BioCentury | May 9, 2016
Financial News

VistaGen amends follow-on

...raised: Up to $13.9 million Shares: 2.4 million Price prior: $8 Underwriters: Chardan Capital Markets; WallachBeth Capital...
BioCentury | Apr 25, 2016
Financial News

VistaGen amends follow-on

...be raised: Up to $13.8 million Shares: TBD Price Prior: $8 Underwriters: Chardan Capital Markets; WallachBeth Capital...
Items per page:
1 - 10 of 12